Journal of Nuclear Medicine

Title Publication Date Language Citations
The Rise of PSMA Ligands for Diagnosis and Therapy of Prostate Cancer2016/10/01English175
Comparative Evaluation of the Translocator Protein Radioligands 11C-DPA-713, 18F-DPA-714, and 11C-PK11195 in a Rat Model of Acute Neuroinflammation2009/02/17English175
Nuclear Myocardial Perfusion Imaging with a Cadmium-Zinc-Telluride Detector Technique: Optimized Protocol for Scan Time Reduction2009/12/15English174
An Assessment of the Impact of Incorporating Time-of-Flight Information into Clinical PET/CT Imaging2010/01/15English174
Dual-Modality Imaging: Combining Anatomy and Function2008/05/15English174
Update on Time-of-Flight PET Imaging2014/12/18English174
2-(2-[2-Dimethylaminothiazol-5-yl]Ethenyl)-6- (2-[Fluoro]Ethoxy)Benzoxazole: A Novel PET Agent for In Vivo Detection of Dense Amyloid Plaques in Alzheimer's Disease Patients2007/04/01English174
Studies of a Next-Generation Silicon-Photomultiplier–Based Time-of-Flight PET/CT System2017/04/27English174
Role of Inflammation in Atherosclerosis2007/11/01English173
Does 18F-FDG PET/CT Improve the Detection of Posttreatment Recurrence of Head and Neck Squamous Cell Carcinoma in Patients Negative for Disease on Clinical Follow-up?2008/12/17English173
Quantitative Accuracy of Clinical 99mTc SPECT/CT Using Ordered-Subset Expectation Maximization with 3-Dimensional Resolution Recovery, Attenuation, and Scatter Correction2010/05/19English173
Prediction of Short-Term Cardiovascular Events Using Quantification of Global Myocardial Flow Reserve in Patients Referred for Clinical 82Rb PET Perfusion Imaging2011/04/15English173
The 18F-FDG PET Cingulate Island Sign and Comparison to 123I-β-CIT SPECT for Diagnosis of Dementia with Lewy Bodies2009/09/16English172
Noise Considerations for PET Quantification Using Maximum and Peak Standardized Uptake Value2012/05/24English172
Synthesis and Preclinical Evaluation of11C-UCB-J as a PET Tracer for Imaging the Synaptic Vesicle Glycoprotein 2A in the Brain2016/02/04English172
Clinical Validation of 18F-AZD4694, an Amyloid-β–Specific PET Radioligand2012/02/09English172
Differentiation of Malignant and Benign Cardiac Tumors Using 18F-FDG PET/CT2012/05/10English172
Brain Amyloid Imaging2011/09/14English171
Prediction of Response to Immune Checkpoint Inhibitor Therapy Using Early-Time-Point18F-FDG PET/CT Imaging in Patients with Advanced Melanoma2017/03/30English171
Quantification of Myocardial Perfusion Reserve Using Dynamic SPECT Imaging in Humans: A Feasibility Study2013/04/11English171
Individualized Dosimetry of Kidney and Bone Marrow in Patients Undergoing 177Lu-DOTA-Octreotate Treatment2012/12/07English171
Efficacy and Toxicity Related to Treatment of Hepatocellular Carcinoma with 90Y-SIR Spheres: Radiobiologic Considerations2010/08/18English170
18F-FDG Uptake in Lung, Breast, and Colon Cancers: Molecular Biology Correlates and Disease Characterization2009/10/16English169
Performance Evaluation of the uEXPLORER Total-Body PET/CT Scanner Based on NEMA NU 2-2018 with Additional Tests to Characterize PET Scanners with a Long Axial Field of View2020/10/02English169
A Novel Facile Method of Labeling Octreotide with 18F-Fluorine2010/02/11English168
Appropriate Use Criteria for Amyloid PET: A Report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer’s Association2013/01/28English168
99mTc-Labeled Small-Molecule Inhibitors of Prostate-Specific Membrane Antigen for Molecular Imaging of Prostate Cancer2013/06/03English168
Comparison of the Biodistribution and Tumor Targeting of Two 99mTc-Labeled Anti-EGFR Nanobodies in Mice, Using Pinhole SPECT/Micro-CT2008/04/15English167
In Vivo Detection of Apoptosis2008/06/01English167
Efficacy and Safety of High-Specific-Activity 131I-MIBG Therapy in Patients with Advanced Pheochromocytoma or Paraganglioma2018/10/05English166